In the third quarter, Asset Management One Co. Ltd. increased its holdings in Medtronic by 2.4%, acquiring an additional 13,594 shares to bring its total to 589,186 shares. At the end of the reporting period, this stake was valued at $56.11 million, reflecting the fund’s continued confidence in Medtronic’s long–term growth prospects within the medical technology sector.

Several other institutional investors also modified their Medtronic positions during the same quarter. Gateway Investment Advisers LLC added 1,405 shares, raising its total to 90,237 shares valued at $8.59 million; DMKC Advisory Services LLC increased its stake by 208 shares to 24,230 shares worth $2.31 million; Moss Adams Wealth Advisors LLC purchased 147 additional shares, bringing its holding to 4,431 shares valued at $425,000; Saxony Capital Management LLC added 112 shares for a total of 3,046 shares worth $290,000; and Global Retirement Partners LLC expanded its position by 4,900 shares to 33,584 shares valued at $3.20 million. Institutional investors now own 82.06% of Medtronic’s outstanding shares.

Medtronic reported third-quarter earnings per share of $1.36, surpassing the consensus estimate of $1.31 by $0.05. Quarterly revenue reached $8.96 billion, up 6.6% year-over-year and exceeding analysts’ $8.86 billion forecast. The company delivered a return on equity of 14.86% and maintained a net margin of 13.71%. For fiscal 2026, management set EPS guidance in the range of 5.620 to 5.660, while research analysts collectively expect full-year EPS of 5.46.

Medtronic announced a quarterly dividend of $0.71 per share, payable on January 16 to shareholders of record as of December 26. This represents an annualized payout of $2.84 and a yield of 3.0%. The company’s dividend payout ratio stands at 76.55%, underscoring its commitment to returning capital to shareholders while maintaining a balanced approach to reinvestment and debt management.